| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 20 | 2022 | 37 | 2.450 |
Why?
|
| Retrospective Studies | 76 | 2024 | 2467 | 2.170 |
Why?
|
| Child | 83 | 2024 | 2497 | 2.140 |
Why?
|
| Telemedicine | 7 | 2023 | 187 | 2.140 |
Why?
|
| Uveitis | 7 | 2022 | 8 | 2.050 |
Why?
|
| Humans | 153 | 2024 | 17822 | 1.880 |
Why?
|
| Child, Preschool | 60 | 2024 | 1424 | 1.680 |
Why?
|
| Male | 111 | 2024 | 10145 | 1.590 |
Why?
|
| Methotrexate | 3 | 2022 | 6 | 1.490 |
Why?
|
| Cardiac Surgical Procedures | 11 | 2022 | 16 | 1.480 |
Why?
|
| Infant | 48 | 2024 | 1198 | 1.440 |
Why?
|
| Female | 108 | 2024 | 12780 | 1.380 |
Why?
|
| Echocardiography | 12 | 2018 | 32 | 1.310 |
Why?
|
| Heart Ventricles | 9 | 2020 | 17 | 1.250 |
Why?
|
| Treatment Outcome | 40 | 2022 | 1265 | 1.230 |
Why?
|
| Infant, Newborn | 43 | 2022 | 858 | 1.220 |
Why?
|
| Adolescent | 50 | 2024 | 3690 | 1.150 |
Why?
|
| Adrenal Hyperplasia, Congenital | 2 | 2024 | 8 | 1.140 |
Why?
|
| Pediatrics | 13 | 2019 | 161 | 1.140 |
Why?
|
| Palliative Care | 12 | 2020 | 61 | 1.120 |
Why?
|
| Intensive Care Units, Pediatric | 10 | 2020 | 15 | 0.930 |
Why?
|
| Body Height | 1 | 2024 | 62 | 0.920 |
Why?
|
| Ambulatory Care | 9 | 2023 | 247 | 0.810 |
Why?
|
| Norwood Procedures | 6 | 2018 | 7 | 0.790 |
Why?
|
| Feeding and Eating Disorders of Childhood | 5 | 2020 | 5 | 0.750 |
Why?
|
| Chronic Pain | 1 | 2023 | 127 | 0.740 |
Why?
|
| Sepsis | 6 | 2018 | 70 | 0.740 |
Why?
|
| Autism Spectrum Disorder | 6 | 2020 | 164 | 0.740 |
Why?
|
| Practice Patterns, Physicians' | 7 | 2019 | 332 | 0.730 |
Why?
|
| Hypoplastic Left Heart Syndrome | 5 | 2018 | 6 | 0.730 |
Why?
|
| Conscious Sedation | 5 | 2020 | 5 | 0.720 |
Why?
|
| Propofol | 6 | 2019 | 6 | 0.700 |
Why?
|
| Risk Factors | 31 | 2019 | 3362 | 0.680 |
Why?
|
| Arthritis, Juvenile | 5 | 2018 | 5 | 0.650 |
Why?
|
| Adalimumab | 1 | 2018 | 5 | 0.630 |
Why?
|
| Infliximab | 1 | 2018 | 7 | 0.630 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2018 | 6 | 0.630 |
Why?
|
| Extracorporeal Membrane Oxygenation | 7 | 2017 | 14 | 0.600 |
Why?
|
| Parents | 7 | 2020 | 297 | 0.590 |
Why?
|
| Cardiologists | 4 | 2018 | 8 | 0.580 |
Why?
|
| Hospital Mortality | 12 | 2018 | 145 | 0.570 |
Why?
|
| Appendicitis | 4 | 2020 | 15 | 0.560 |
Why?
|
| Length of Stay | 8 | 2020 | 182 | 0.550 |
Why?
|
| Hospitals, Pediatric | 7 | 2020 | 79 | 0.510 |
Why?
|
| Guideline Adherence | 4 | 2017 | 158 | 0.500 |
Why?
|
| Nephrotic Syndrome | 3 | 2020 | 5 | 0.490 |
Why?
|
| Hypnotics and Sedatives | 4 | 2020 | 18 | 0.480 |
Why?
|
| Adult | 25 | 2023 | 7708 | 0.470 |
Why?
|
| Risk Assessment | 13 | 2019 | 1103 | 0.460 |
Why?
|
| Heart Transplantation | 5 | 2020 | 11 | 0.460 |
Why?
|
| Georgia | 13 | 2023 | 26 | 0.460 |
Why?
|
| Time Factors | 17 | 2019 | 1097 | 0.460 |
Why?
|
| Vesico-Ureteral Reflux | 3 | 2020 | 7 | 0.450 |
Why?
|
| Severity of Illness Index | 8 | 2019 | 455 | 0.450 |
Why?
|
| Clinical Competence | 4 | 2019 | 100 | 0.450 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 107 | 0.440 |
Why?
|
| Pandemics | 7 | 2023 | 287 | 0.440 |
Why?
|
| Feeding Behavior | 3 | 2020 | 166 | 0.440 |
Why?
|
| Behavior Therapy | 3 | 2020 | 146 | 0.430 |
Why?
|
| Education, Medical, Graduate | 3 | 2018 | 18 | 0.420 |
Why?
|
| Young Adult | 13 | 2024 | 2464 | 0.420 |
Why?
|
| Shock, Septic | 3 | 2019 | 9 | 0.420 |
Why?
|
| Abnormalities, Multiple | 3 | 2018 | 11 | 0.420 |
Why?
|
| Simulation Training | 3 | 2019 | 4 | 0.420 |
Why?
|
| Cardiac Catheterization | 4 | 2021 | 8 | 0.420 |
Why?
|
| Comorbidity | 9 | 2023 | 597 | 0.400 |
Why?
|
| Diagnostic Imaging | 3 | 2020 | 45 | 0.400 |
Why?
|
| Cohort Studies | 17 | 2022 | 2590 | 0.400 |
Why?
|
| Postoperative Complications | 6 | 2018 | 102 | 0.390 |
Why?
|
| Cause of Death | 3 | 2018 | 181 | 0.390 |
Why?
|
| Blalock-Taussig Procedure | 4 | 2021 | 4 | 0.390 |
Why?
|
| Cystic Fibrosis | 2 | 2022 | 8 | 0.380 |
Why?
|
| Prospective Studies | 14 | 2020 | 1286 | 0.380 |
Why?
|
| Transgender Persons | 2 | 2023 | 38 | 0.380 |
Why?
|
| Attitude of Health Personnel | 3 | 2018 | 214 | 0.380 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2021 | 2 | 0.360 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2020 | 211 | 0.360 |
Why?
|
| Survival Rate | 11 | 2018 | 260 | 0.360 |
Why?
|
| Survival Analysis | 11 | 2020 | 216 | 0.360 |
Why?
|
| Follow-Up Studies | 14 | 2017 | 1219 | 0.360 |
Why?
|
| Anesthetics, Intravenous | 4 | 2017 | 4 | 0.340 |
Why?
|
| Prevalence | 12 | 2023 | 888 | 0.330 |
Why?
|
| Mobile Applications | 2 | 2020 | 19 | 0.330 |
Why?
|
| United States | 17 | 2023 | 4007 | 0.330 |
Why?
|
| Ductus Arteriosus | 2 | 2021 | 2 | 0.320 |
Why?
|
| Fontan Procedure | 3 | 2018 | 5 | 0.320 |
Why?
|
| Research Design | 2 | 2023 | 376 | 0.310 |
Why?
|
| Quality of Life | 4 | 2015 | 511 | 0.310 |
Why?
|
| Appendectomy | 2 | 2020 | 4 | 0.300 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 246 | 0.300 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2018 | 3 | 0.300 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 6 | 0.300 |
Why?
|
| Practice Guidelines as Topic | 7 | 2020 | 321 | 0.300 |
Why?
|
| Recurrence | 4 | 2022 | 189 | 0.290 |
Why?
|
| Utilization Review | 3 | 2017 | 53 | 0.290 |
Why?
|
| Cerebral Hemorrhage | 2 | 2019 | 14 | 0.290 |
Why?
|
| Aortic Coarctation | 2 | 2019 | 3 | 0.290 |
Why?
|
| Food Preferences | 2 | 2019 | 25 | 0.290 |
Why?
|
| Internship and Residency | 2 | 2019 | 46 | 0.290 |
Why?
|
| Cardiology | 2 | 2018 | 30 | 0.290 |
Why?
|
| Anemia, Sickle Cell | 2 | 2020 | 9 | 0.280 |
Why?
|
| Human Trafficking | 2 | 2018 | 4 | 0.280 |
Why?
|
| Immunosuppressive Agents | 3 | 2022 | 20 | 0.280 |
Why?
|
| Problem Behavior | 2 | 2017 | 4 | 0.280 |
Why?
|
| Fundoplication | 2 | 2017 | 2 | 0.280 |
Why?
|
| Tricuspid Valve | 2 | 2018 | 2 | 0.280 |
Why?
|
| Feeding and Eating Disorders | 2 | 2017 | 17 | 0.280 |
Why?
|
| Child Behavior | 2 | 2017 | 22 | 0.280 |
Why?
|
| Prognosis | 8 | 2020 | 609 | 0.270 |
Why?
|
| Anesthesia | 2 | 2018 | 4 | 0.270 |
Why?
|
| Aneurysm, Ruptured | 2 | 2017 | 2 | 0.270 |
Why?
|
| Intracranial Aneurysm | 2 | 2017 | 4 | 0.270 |
Why?
|
| Crohn Disease | 2 | 2017 | 14 | 0.270 |
Why?
|
| Stents | 3 | 2022 | 11 | 0.270 |
Why?
|
| Pulmonary Atresia | 2 | 2017 | 2 | 0.270 |
Why?
|
| Gastroesophageal Reflux | 2 | 2017 | 79 | 0.270 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2016 | 6 | 0.270 |
Why?
|
| Reoperation | 8 | 2020 | 30 | 0.260 |
Why?
|
| Drainage | 2 | 2016 | 4 | 0.260 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2019 | 129 | 0.260 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 204 | 0.260 |
Why?
|
| Eating | 2 | 2017 | 37 | 0.250 |
Why?
|
| Catheterization, Central Venous | 2 | 2015 | 13 | 0.250 |
Why?
|
| Hypertension, Pulmonary | 2 | 2015 | 8 | 0.250 |
Why?
|
| Ultrasonography | 3 | 2020 | 36 | 0.240 |
Why?
|
| Databases, Factual | 8 | 2019 | 315 | 0.240 |
Why?
|
| Critical Care | 4 | 2020 | 71 | 0.240 |
Why?
|
| Transsexualism | 2 | 2023 | 10 | 0.230 |
Why?
|
| Anthropometry | 1 | 2024 | 66 | 0.230 |
Why?
|
| Deep Sedation | 2 | 2014 | 3 | 0.230 |
Why?
|
| Age Factors | 8 | 2020 | 923 | 0.230 |
Why?
|
| Laparoscopy | 3 | 2020 | 49 | 0.230 |
Why?
|
| Pain | 2 | 2016 | 79 | 0.230 |
Why?
|
| Rhinovirus | 2 | 2014 | 2 | 0.230 |
Why?
|
| Surveys and Questionnaires | 6 | 2019 | 1323 | 0.220 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2014 | 33 | 0.220 |
Why?
|
| Data Accuracy | 2 | 2021 | 27 | 0.220 |
Why?
|
| Pulmonary Circulation | 2 | 2021 | 2 | 0.220 |
Why?
|
| Body Weight | 1 | 2024 | 224 | 0.210 |
Why?
|
| Pseudomonas Infections | 1 | 2022 | 3 | 0.210 |
Why?
|
| Virus Diseases | 1 | 2022 | 6 | 0.210 |
Why?
|
| Standard of Care | 2 | 2020 | 7 | 0.210 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2022 | 3 | 0.210 |
Why?
|
| RNA, Viral | 2 | 2020 | 65 | 0.210 |
Why?
|
| Sexual and Gender Minorities | 1 | 2023 | 27 | 0.210 |
Why?
|
| Hypertension | 2 | 2019 | 505 | 0.200 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 69 | 0.200 |
Why?
|
| Stenosis, Pulmonary Vein | 1 | 2022 | 1 | 0.200 |
Why?
|
| Angioplasty, Balloon | 1 | 2022 | 1 | 0.200 |
Why?
|
| Pulmonary Veins | 1 | 2022 | 1 | 0.200 |
Why?
|
| Drug-Eluting Stents | 1 | 2022 | 8 | 0.200 |
Why?
|
| Self-Injurious Behavior | 1 | 2023 | 45 | 0.200 |
Why?
|
| Reproducibility of Results | 6 | 2020 | 381 | 0.200 |
Why?
|
| Tetralogy of Fallot | 1 | 2022 | 2 | 0.200 |
Why?
|
| Pneumonia | 1 | 2022 | 51 | 0.200 |
Why?
|
| Cardiovascular Diseases | 3 | 2017 | 599 | 0.200 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2018 | 41 | 0.200 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 124 | 0.190 |
Why?
|
| Wounds and Injuries | 2 | 2019 | 47 | 0.190 |
Why?
|
| Outpatients | 3 | 2017 | 110 | 0.190 |
Why?
|
| Cross-Sectional Studies | 7 | 2020 | 1335 | 0.190 |
Why?
|
| Emergency Service, Hospital | 3 | 2020 | 368 | 0.190 |
Why?
|
| Antidepressive Agents | 1 | 2023 | 156 | 0.190 |
Why?
|
| Depression | 2 | 2023 | 506 | 0.190 |
Why?
|
| Marfan Syndrome | 1 | 2021 | 1 | 0.190 |
Why?
|
| Postoperative Care | 3 | 2017 | 20 | 0.190 |
Why?
|
| Methylphenidate | 1 | 2021 | 4 | 0.180 |
Why?
|
| Abatacept | 1 | 2021 | 1 | 0.180 |
Why?
|
| Graft vs Host Disease | 1 | 2021 | 1 | 0.180 |
Why?
|
| Crime Victims | 2 | 2018 | 25 | 0.180 |
Why?
|
| Ventricular Function, Right | 2 | 2018 | 2 | 0.180 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 9 | 0.180 |
Why?
|
| Punctures | 2 | 2019 | 2 | 0.180 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2020 | 1 | 0.180 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2020 | 1 | 0.180 |
Why?
|
| Viral Envelope Proteins | 1 | 2020 | 2 | 0.180 |
Why?
|
| Zika Virus | 1 | 2020 | 2 | 0.180 |
Why?
|
| Education, Nonprofessional | 2 | 2017 | 6 | 0.180 |
Why?
|
| Zika Virus Infection | 1 | 2020 | 4 | 0.180 |
Why?
|
| Brain | 2 | 2020 | 47 | 0.180 |
Why?
|
| Central Nervous System Stimulants | 1 | 2021 | 27 | 0.180 |
Why?
|
| Acute Chest Syndrome | 1 | 2020 | 1 | 0.180 |
Why?
|
| Point-of-Care Testing | 1 | 2020 | 3 | 0.180 |
Why?
|
| Lung | 2 | 2022 | 62 | 0.180 |
Why?
|
| Infectious Encephalitis | 1 | 2020 | 1 | 0.180 |
Why?
|
| Encephalitis | 1 | 2020 | 5 | 0.180 |
Why?
|
| Treatment Refusal | 1 | 2020 | 33 | 0.180 |
Why?
|
| Quality Improvement | 3 | 2017 | 194 | 0.180 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 11 | 0.180 |
Why?
|
| Aorta | 2 | 2021 | 5 | 0.180 |
Why?
|
| Heart Valves | 1 | 2020 | 4 | 0.180 |
Why?
|
| Enteral Nutrition | 1 | 2020 | 6 | 0.180 |
Why?
|
| Estradiol | 1 | 2020 | 24 | 0.170 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 65 | 0.170 |
Why?
|
| Head | 1 | 2020 | 8 | 0.170 |
Why?
|
| Sarcoma, Ewing | 1 | 2020 | 2 | 0.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 64 | 0.170 |
Why?
|
| Spinal Dysraphism | 1 | 2019 | 2 | 0.170 |
Why?
|
| Axillary Artery | 1 | 2019 | 1 | 0.170 |
Why?
|
| Femoral Artery | 1 | 2019 | 4 | 0.170 |
Why?
|
| Intestinal Perforation | 1 | 2020 | 8 | 0.170 |
Why?
|
| Carotid Arteries | 1 | 2019 | 9 | 0.170 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 3 | 0.170 |
Why?
|
| Body Mass Index | 1 | 2024 | 967 | 0.170 |
Why?
|
| Mental Disorders | 1 | 2023 | 280 | 0.170 |
Why?
|
| Restraint, Physical | 1 | 2019 | 1 | 0.170 |
Why?
|
| Radiology | 1 | 2019 | 8 | 0.170 |
Why?
|
| Self-Management | 1 | 2020 | 29 | 0.170 |
Why?
|
| Bone Density | 1 | 2020 | 97 | 0.170 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 19 | 0.170 |
Why?
|
| Vitamin D | 3 | 2020 | 76 | 0.170 |
Why?
|
| Feeding Methods | 1 | 2019 | 1 | 0.170 |
Why?
|
| Motor Skills Disorders | 1 | 2019 | 2 | 0.170 |
Why?
|
| Electronic Health Records | 2 | 2023 | 698 | 0.160 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2019 | 4 | 0.160 |
Why?
|
| Firearms | 1 | 2020 | 32 | 0.160 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 711 | 0.160 |
Why?
|
| Urinalysis | 1 | 2019 | 9 | 0.160 |
Why?
|
| Hernia, Umbilical | 1 | 2019 | 1 | 0.160 |
Why?
|
| Medical Informatics Applications | 1 | 2019 | 8 | 0.160 |
Why?
|
| Health Literacy | 1 | 2019 | 39 | 0.160 |
Why?
|
| Poisoning | 1 | 2019 | 5 | 0.160 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2019 | 3 | 0.160 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 40 | 0.160 |
Why?
|
| Surgeons | 1 | 2019 | 11 | 0.160 |
Why?
|
| Registries | 3 | 2016 | 472 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 417 | 0.160 |
Why?
|
| Work-Life Balance | 1 | 2018 | 1 | 0.160 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2018 | 2 | 0.160 |
Why?
|
| Visual Acuity | 2 | 2015 | 21 | 0.160 |
Why?
|
| Mucin 5AC | 1 | 2018 | 2 | 0.160 |
Why?
|
| Respiratory Insufficiency | 2 | 2015 | 17 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 27 | 0.160 |
Why?
|
| Patient Admission | 1 | 2019 | 72 | 0.160 |
Why?
|
| Burnout, Professional | 1 | 2018 | 14 | 0.160 |
Why?
|
| Arterial Switch Operation | 1 | 2018 | 1 | 0.160 |
Why?
|
| Transposition of Great Vessels | 1 | 2018 | 2 | 0.160 |
Why?
|
| Pediatricians | 1 | 2018 | 15 | 0.160 |
Why?
|
| Workplace | 1 | 2018 | 30 | 0.160 |
Why?
|
| Job Satisfaction | 1 | 2018 | 21 | 0.160 |
Why?
|
| Patient Compliance | 2 | 2023 | 301 | 0.160 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2018 | 21 | 0.150 |
Why?
|
| Workload | 1 | 2018 | 30 | 0.150 |
Why?
|
| Preventive Health Services | 1 | 2020 | 160 | 0.150 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2018 | 29 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 88 | 0.150 |
Why?
|
| Respiration, Artificial | 2 | 2019 | 37 | 0.150 |
Why?
|
| Plasma Exchange | 1 | 2018 | 1 | 0.150 |
Why?
|
| Multivariate Analysis | 5 | 2019 | 569 | 0.150 |
Why?
|
| Patient Care Team | 2 | 2016 | 114 | 0.150 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 151 | 0.150 |
Why?
|
| Epithelial Cells | 2 | 2014 | 6 | 0.150 |
Why?
|
| African Americans | 3 | 2020 | 472 | 0.150 |
Why?
|
| Cystography | 1 | 2017 | 1 | 0.150 |
Why?
|
| Urologic Surgical Procedures | 1 | 2017 | 7 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 186 | 0.150 |
Why?
|
| Resuscitation | 1 | 2017 | 3 | 0.140 |
Why?
|
| DiGeorge Syndrome | 1 | 2017 | 2 | 0.140 |
Why?
|
| Cycloserine | 1 | 2017 | 1 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 1 | 0.140 |
Why?
|
| Urinary Tract Infections | 1 | 2017 | 20 | 0.140 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2017 | 12 | 0.140 |
Why?
|
| Odds Ratio | 5 | 2017 | 673 | 0.140 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2017 | 1 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 247 | 0.140 |
Why?
|
| Fluid Therapy | 1 | 2017 | 11 | 0.140 |
Why?
|
| Reticulocytes | 1 | 2017 | 1 | 0.140 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 2 | 0.140 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 4 | 0.140 |
Why?
|
| Electromyography | 1 | 2017 | 6 | 0.140 |
Why?
|
| Coronary Circulation | 1 | 2017 | 4 | 0.140 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2017 | 7 | 0.140 |
Why?
|
| Colitis, Ulcerative | 1 | 2017 | 9 | 0.140 |
Why?
|
| Heart Auscultation | 1 | 2017 | 1 | 0.140 |
Why?
|
| Heart Sounds | 1 | 2017 | 1 | 0.140 |
Why?
|
| Systolic Murmurs | 1 | 2017 | 1 | 0.140 |
Why?
|
| Methohexital | 1 | 2017 | 1 | 0.140 |
Why?
|
| Aortic Valve | 1 | 2017 | 4 | 0.140 |
Why?
|
| Cardiology Service, Hospital | 1 | 2017 | 2 | 0.140 |
Why?
|
| Heart Valve Diseases | 1 | 2017 | 20 | 0.140 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 34 | 0.140 |
Why?
|
| Syncope | 1 | 2017 | 12 | 0.140 |
Why?
|
| Heel | 1 | 2016 | 1 | 0.140 |
Why?
|
| Vibration | 1 | 2016 | 1 | 0.140 |
Why?
|
| Hemoglobins | 1 | 2017 | 39 | 0.140 |
Why?
|
| Cicatrix | 1 | 2016 | 2 | 0.140 |
Why?
|
| Pelvis | 1 | 2016 | 3 | 0.140 |
Why?
|
| Surgical Stapling | 1 | 2016 | 1 | 0.140 |
Why?
|
| Pleurodesis | 1 | 2016 | 1 | 0.140 |
Why?
|
| Pneumothorax | 1 | 2016 | 2 | 0.140 |
Why?
|
| Nutritional Requirements | 1 | 2016 | 6 | 0.140 |
Why?
|
| Thoracoscopy | 1 | 2016 | 3 | 0.140 |
Why?
|
| Pneumonectomy | 1 | 2016 | 7 | 0.140 |
Why?
|
| Risperidone | 1 | 2016 | 3 | 0.140 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2016 | 6 | 0.140 |
Why?
|
| Nutritional Status | 1 | 2016 | 31 | 0.140 |
Why?
|
| Aortic Arch Syndromes | 1 | 2016 | 1 | 0.140 |
Why?
|
| Electrocardiography | 1 | 2016 | 42 | 0.130 |
Why?
|
| Cerebral Ventricles | 1 | 2016 | 2 | 0.130 |
Why?
|
| Continental Population Groups | 2 | 2015 | 302 | 0.130 |
Why?
|
| Gastroschisis | 1 | 2016 | 1 | 0.130 |
Why?
|
| Candidiasis | 1 | 2016 | 2 | 0.130 |
Why?
|
| Heart Arrest | 1 | 2016 | 34 | 0.130 |
Why?
|
| Aortopulmonary Septal Defect | 1 | 2016 | 1 | 0.130 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2016 | 10 | 0.130 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 24 | 0.130 |
Why?
|
| Kidney | 1 | 2016 | 53 | 0.130 |
Why?
|
| Walking | 1 | 2017 | 86 | 0.130 |
Why?
|
| Palliative Medicine | 1 | 2016 | 1 | 0.130 |
Why?
|
| Family Therapy | 1 | 2016 | 6 | 0.130 |
Why?
|
| Neonatal Sepsis | 1 | 2016 | 5 | 0.130 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 7 | 0.130 |
Why?
|
| Hospice Care | 1 | 2016 | 9 | 0.130 |
Why?
|
| Anesthesia, General | 1 | 2016 | 3 | 0.130 |
Why?
|
| Patient Preference | 1 | 2016 | 48 | 0.130 |
Why?
|
| Heterotaxy Syndrome | 1 | 2016 | 1 | 0.130 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 6 | 0.130 |
Why?
|
| Autoimmunity | 1 | 2016 | 4 | 0.130 |
Why?
|
| Rheumatology | 1 | 2016 | 6 | 0.130 |
Why?
|
| Antipsychotic Agents | 1 | 2016 | 49 | 0.130 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 1 | 0.130 |
Why?
|
| Cholecalciferol | 1 | 2016 | 15 | 0.130 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2015 | 1 | 0.130 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2015 | 8 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 17 | 0.130 |
Why?
|
| Jugular Veins | 1 | 2015 | 2 | 0.130 |
Why?
|
| Caliciviridae Infections | 1 | 2015 | 5 | 0.130 |
Why?
|
| Norovirus | 1 | 2015 | 5 | 0.130 |
Why?
|
| Embolization, Therapeutic | 1 | 2015 | 6 | 0.130 |
Why?
|
| Renal Replacement Therapy | 1 | 2015 | 9 | 0.130 |
Why?
|
| Hemophilia A | 1 | 2015 | 1 | 0.130 |
Why?
|
| Isoantibodies | 1 | 2015 | 1 | 0.130 |
Why?
|
| Factor VIII | 1 | 2015 | 2 | 0.130 |
Why?
|
| Central Venous Catheters | 1 | 2015 | 4 | 0.130 |
Why?
|
| Digoxin | 1 | 2016 | 12 | 0.130 |
Why?
|
| Immunosuppression | 1 | 2015 | 7 | 0.130 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 24 | 0.130 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2015 | 1 | 0.130 |
Why?
|
| Vascular Malformations | 1 | 2015 | 1 | 0.130 |
Why?
|
| Aorta, Thoracic | 1 | 2015 | 2 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 4 | 0.130 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 1 | 0.130 |
Why?
|
| Steroids | 1 | 2015 | 14 | 0.130 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 21 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2018 | 428 | 0.130 |
Why?
|
| Deep Brain Stimulation | 1 | 2015 | 1 | 0.130 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2015 | 2 | 0.130 |
Why?
|
| Tricuspid Atresia | 1 | 2015 | 2 | 0.130 |
Why?
|
| HLA-DRB1 Chains | 1 | 2015 | 13 | 0.130 |
Why?
|
| DNA | 1 | 2015 | 22 | 0.130 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 23 | 0.130 |
Why?
|
| Hippocampus | 1 | 2015 | 7 | 0.130 |
Why?
|
| Immunization | 1 | 2016 | 70 | 0.130 |
Why?
|
| Heart Septal Defects | 1 | 2015 | 1 | 0.130 |
Why?
|
| Gastroenteritis | 1 | 2015 | 27 | 0.120 |
Why?
|
| Seizures | 1 | 2015 | 29 | 0.120 |
Why?
|
| Sex Work | 1 | 2015 | 5 | 0.120 |
Why?
|
| Vitamins | 1 | 2016 | 64 | 0.120 |
Why?
|
| Patient Safety | 1 | 2015 | 39 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 68 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2016 | 86 | 0.120 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2015 | 1 | 0.120 |
Why?
|
| Child Abuse, Sexual | 1 | 2015 | 14 | 0.120 |
Why?
|
| Feces | 1 | 2015 | 80 | 0.120 |
Why?
|
| Respiratory System | 1 | 2014 | 3 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 9 | 0.120 |
Why?
|
| Chemokines | 1 | 2014 | 8 | 0.120 |
Why?
|
| Critical Care Nursing | 1 | 2014 | 2 | 0.120 |
Why?
|
| Nursing Staff, Hospital | 1 | 2014 | 11 | 0.120 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2014 | 3 | 0.120 |
Why?
|
| Infection Control | 1 | 2014 | 10 | 0.120 |
Why?
|
| Bacteremia | 1 | 2014 | 12 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2014 | 1 | 0.120 |
Why?
|
| Virus Activation | 1 | 2014 | 6 | 0.120 |
Why?
|
| Cytomegalovirus | 1 | 2014 | 3 | 0.120 |
Why?
|
| Thinness | 1 | 2014 | 30 | 0.120 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 537 | 0.120 |
Why?
|
| European Continental Ancestry Group | 2 | 2015 | 529 | 0.120 |
Why?
|
| Sensitivity and Specificity | 4 | 2016 | 305 | 0.120 |
Why?
|
| International Classification of Diseases | 1 | 2015 | 85 | 0.120 |
Why?
|
| Cross Infection | 1 | 2014 | 27 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2016 | 169 | 0.120 |
Why?
|
| Anesthesia, Intravenous | 1 | 2014 | 1 | 0.120 |
Why?
|
| Operating Rooms | 1 | 2014 | 3 | 0.120 |
Why?
|
| Airway Extubation | 1 | 2014 | 2 | 0.110 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2014 | 7 | 0.110 |
Why?
|
| Medical Staff, Hospital | 1 | 2014 | 7 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 1 | 2014 | 27 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2016 | 229 | 0.110 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 201 | 0.110 |
Why?
|
| Common Cold | 1 | 2013 | 2 | 0.110 |
Why?
|
| Trachea | 1 | 2013 | 2 | 0.110 |
Why?
|
| Monocytes | 1 | 2013 | 5 | 0.110 |
Why?
|
| ROC Curve | 3 | 2018 | 77 | 0.110 |
Why?
|
| Stroke | 1 | 2016 | 315 | 0.110 |
Why?
|
| Middle Aged | 7 | 2021 | 8020 | 0.110 |
Why?
|
| Energy Intake | 1 | 2013 | 101 | 0.110 |
Why?
|
| Feasibility Studies | 3 | 2020 | 114 | 0.110 |
Why?
|
| Logistic Models | 4 | 2016 | 928 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 161 | 0.110 |
Why?
|
| Ascariasis | 1 | 2013 | 1 | 0.110 |
Why?
|
| Mass Screening | 1 | 2018 | 678 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 373 | 0.100 |
Why?
|
| Biomarkers | 3 | 2018 | 310 | 0.100 |
Why?
|
| Malaria | 1 | 2013 | 17 | 0.100 |
Why?
|
| Coinfection | 1 | 2013 | 30 | 0.100 |
Why?
|
| Anemia | 1 | 2013 | 34 | 0.100 |
Why?
|
| Recovery of Function | 3 | 2017 | 27 | 0.100 |
Why?
|
| Gender Identity | 2 | 2023 | 36 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 329 | 0.100 |
Why?
|
| Infant Mortality | 3 | 2016 | 20 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2013 | 141 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2015 | 12 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2016 | 219 | 0.090 |
Why?
|
| Double-Blind Method | 3 | 2017 | 160 | 0.090 |
Why?
|
| Animals | 3 | 2017 | 262 | 0.090 |
Why?
|
| Physicians | 3 | 2018 | 138 | 0.090 |
Why?
|
| Aged | 5 | 2021 | 6173 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2020 | 1120 | 0.080 |
Why?
|
| Caregivers | 2 | 2020 | 129 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 354 | 0.080 |
Why?
|
| HIV Infections | 1 | 2015 | 707 | 0.080 |
Why?
|
| Academic Medical Centers | 2 | 2018 | 30 | 0.080 |
Why?
|
| Linear Models | 2 | 2018 | 232 | 0.070 |
Why?
|
| Cell Line | 2 | 2020 | 10 | 0.070 |
Why?
|
| Age of Onset | 2 | 2020 | 79 | 0.070 |
Why?
|
| Multiple Organ Failure | 2 | 2018 | 12 | 0.070 |
Why?
|
| Infant, Low Birth Weight | 2 | 2018 | 35 | 0.070 |
Why?
|
| Models, Statistical | 2 | 2019 | 178 | 0.070 |
Why?
|
| Vasoconstrictor Agents | 2 | 2017 | 7 | 0.070 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 58 | 0.070 |
Why?
|
| Survivors | 2 | 2019 | 150 | 0.070 |
Why?
|
| Quality Control | 2 | 2016 | 45 | 0.060 |
Why?
|
| Heart Diseases | 2 | 2017 | 77 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 60 | 0.060 |
Why?
|
| Sexual Behavior | 2 | 2018 | 124 | 0.060 |
Why?
|
| Patient Selection | 2 | 2017 | 190 | 0.060 |
Why?
|
| Confidence Intervals | 2 | 2016 | 237 | 0.060 |
Why?
|
| Risk | 2 | 2019 | 518 | 0.060 |
Why?
|
| Diarrhea | 2 | 2015 | 13 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 129 | 0.060 |
Why?
|
| Age Distribution | 2 | 2017 | 246 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 12 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2022 | 2 | 0.050 |
Why?
|
| Back Pain | 1 | 2023 | 33 | 0.050 |
Why?
|
| Cost Sharing | 1 | 2023 | 30 | 0.050 |
Why?
|
| Hospitalization | 2 | 2019 | 810 | 0.050 |
Why?
|
| Sexual Development | 1 | 2022 | 4 | 0.050 |
Why?
|
| Forced Expiratory Volume | 1 | 2022 | 69 | 0.050 |
Why?
|
| Colorado | 1 | 2023 | 164 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2021 | 3 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2023 | 212 | 0.050 |
Why?
|
| Mental Health | 1 | 2023 | 166 | 0.050 |
Why?
|
| Losartan | 1 | 2021 | 1 | 0.050 |
Why?
|
| Atenolol | 1 | 2021 | 8 | 0.050 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2021 | 10 | 0.050 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2021 | 4 | 0.050 |
Why?
|
| Tacrolimus | 1 | 2021 | 1 | 0.050 |
Why?
|
| Cyclosporine | 1 | 2021 | 1 | 0.050 |
Why?
|
| Induction Chemotherapy | 1 | 2020 | 3 | 0.050 |
Why?
|
| Transfection | 1 | 2020 | 6 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 4 | 0.050 |
Why?
|
| Demography | 1 | 2020 | 101 | 0.040 |
Why?
|
| Blood | 1 | 2020 | 1 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2020 | 2 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 19 | 0.040 |
Why?
|
| Health Status | 1 | 2022 | 299 | 0.040 |
Why?
|
| Audiovisual Aids | 1 | 2020 | 3 | 0.040 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 2020 | 1 | 0.040 |
Why?
|
| Urography | 1 | 2020 | 2 | 0.040 |
Why?
|
| Urination | 1 | 2020 | 2 | 0.040 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 4 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2020 | 28 | 0.040 |
Why?
|
| Cervical Cord | 1 | 2019 | 1 | 0.040 |
Why?
|
| Trauma Centers | 1 | 2019 | 7 | 0.040 |
Why?
|
| Rural Population | 1 | 2020 | 52 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 19 | 0.040 |
Why?
|
| Neurological Rehabilitation | 1 | 2019 | 1 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 4 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2019 | 8 | 0.040 |
Why?
|
| Urine | 1 | 2019 | 5 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 10 | 0.040 |
Why?
|
| Proteins | 1 | 2019 | 16 | 0.040 |
Why?
|
| Herniorrhaphy | 1 | 2019 | 3 | 0.040 |
Why?
|
| Smartphone | 1 | 2019 | 11 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 17 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 135 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2019 | 159 | 0.040 |
Why?
|
| Argentina | 1 | 2018 | 2 | 0.040 |
Why?
|
| Program Development | 1 | 2019 | 69 | 0.040 |
Why?
|
| Nose | 1 | 2018 | 3 | 0.040 |
Why?
|
| Health Risk Behaviors | 1 | 2018 | 6 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2019 | 92 | 0.040 |
Why?
|
| Human Genetics | 1 | 2018 | 1 | 0.040 |
Why?
|
| Chromosome Disorders | 1 | 2018 | 3 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 50 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 100 | 0.040 |
Why?
|
| Lymphopenia | 1 | 2018 | 1 | 0.040 |
Why?
|
| Anesthesiology | 1 | 2018 | 2 | 0.040 |
Why?
|
| Neutropenia | 1 | 2018 | 3 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2018 | 19 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 15 | 0.040 |
Why?
|
| Global Health | 1 | 2018 | 33 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2019 | 223 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2018 | 75 | 0.040 |
Why?
|
| Urethra | 1 | 2017 | 1 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2017 | 9 | 0.040 |
Why?
|
| Cannula | 1 | 2017 | 2 | 0.040 |
Why?
|
| Conditioning, Operant | 1 | 2017 | 1 | 0.040 |
Why?
|
| Extinction, Psychological | 1 | 2017 | 1 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2017 | 9 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 4 | 0.040 |
Why?
|
| Avoidance Learning | 1 | 2017 | 3 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 18 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 630 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2019 | 303 | 0.040 |
Why?
|
| Retreatment | 1 | 2017 | 10 | 0.040 |
Why?
|
| Cerebral Angiography | 1 | 2017 | 6 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2017 | 7 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2017 | 43 | 0.040 |
Why?
|
| Fever | 1 | 2017 | 55 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2017 | 64 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2016 | 7 | 0.030 |
Why?
|
| Oximetry | 1 | 2016 | 3 | 0.030 |
Why?
|
| Sucrose | 1 | 2016 | 7 | 0.030 |
Why?
|
| Blood Specimen Collection | 1 | 2016 | 8 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 154 | 0.030 |
Why?
|
| Crowdsourcing | 1 | 2016 | 3 | 0.030 |
Why?
|
| Sweetening Agents | 1 | 2016 | 11 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 20 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2017 | 44 | 0.030 |
Why?
|
| Heart Rate | 1 | 2016 | 41 | 0.030 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2016 | 1 | 0.030 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2016 | 2 | 0.030 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 6 | 0.030 |
Why?
|
| Long QT Syndrome | 1 | 2016 | 6 | 0.030 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2016 | 6 | 0.030 |
Why?
|
| Intensive Care, Neonatal | 1 | 2016 | 5 | 0.030 |
Why?
|
| Pain Management | 1 | 2016 | 58 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 75 | 0.030 |
Why?
|
| Trimedoxime | 1 | 2016 | 1 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2016 | 35 | 0.030 |
Why?
|
| Manuals as Topic | 1 | 2016 | 7 | 0.030 |
Why?
|
| Wound Healing | 1 | 2016 | 5 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 13 | 0.030 |
Why?
|
| Meals | 1 | 2016 | 7 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2016 | 39 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2016 | 10 | 0.030 |
Why?
|
| Curriculum | 1 | 2016 | 36 | 0.030 |
Why?
|
| Phylogeny | 1 | 2015 | 14 | 0.030 |
Why?
|
| Calcium | 1 | 2016 | 35 | 0.030 |
Why?
|
| Vision Tests | 1 | 2015 | 1 | 0.030 |
Why?
|
| Vision, Ocular | 1 | 2015 | 2 | 0.030 |
Why?
|
| Plasmapheresis | 1 | 2015 | 1 | 0.030 |
Why?
|
| Models, Immunological | 1 | 2015 | 3 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 30 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 15 | 0.030 |
Why?
|
| Adrenal Insufficiency | 1 | 2015 | 1 | 0.030 |
Why?
|
| Endocrinology | 1 | 2015 | 1 | 0.030 |
Why?
|
| Perinatal Mortality | 1 | 2015 | 4 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2015 | 4 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 147 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2015 | 2 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 10 | 0.030 |
Why?
|
| Theta Rhythm | 1 | 2015 | 1 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 9 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2015 | 18 | 0.030 |
Why?
|
| Rats | 1 | 2015 | 30 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 26 | 0.030 |
Why?
|
| Proxy | 1 | 2015 | 4 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2016 | 60 | 0.030 |
Why?
|
| Alleles | 1 | 2015 | 85 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 227 | 0.030 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2015 | 35 | 0.030 |
Why?
|
| Child Protective Services | 1 | 2015 | 3 | 0.030 |
Why?
|
| Homeless Youth | 1 | 2015 | 6 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 57 | 0.030 |
Why?
|
| Gestational Age | 1 | 2015 | 112 | 0.030 |
Why?
|
| Exposure to Violence | 1 | 2015 | 10 | 0.030 |
Why?
|
| Graft Survival | 1 | 2015 | 3 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2015 | 35 | 0.030 |
Why?
|
| Propensity Score | 1 | 2015 | 85 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2015 | 5 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2014 | 4 | 0.030 |
Why?
|
| Virus Replication | 1 | 2014 | 13 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2014 | 13 | 0.030 |
Why?
|
| Organ Dysfunction Scores | 1 | 2014 | 3 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2015 | 105 | 0.030 |
Why?
|
| Respiration | 1 | 2014 | 8 | 0.030 |
Why?
|
| Enterocolitis | 1 | 2014 | 1 | 0.030 |
Why?
|
| Constipation | 1 | 2014 | 4 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2014 | 35 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2015 | 109 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2014 | 15 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 300 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2014 | 16 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2016 | 154 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2014 | 100 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 267 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2013 | 1 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2013 | 190 | 0.030 |
Why?
|
| Cytokines | 1 | 2013 | 30 | 0.030 |
Why?
|
| Anthelmintics | 1 | 2013 | 1 | 0.030 |
Why?
|
| Ascaris lumbricoides | 1 | 2013 | 1 | 0.030 |
Why?
|
| Nigeria | 1 | 2013 | 4 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 644 | 0.030 |
Why?
|
| Calcifediol | 1 | 2012 | 3 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2015 | 246 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 720 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 391 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1269 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 1529 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2015 | 434 | 0.020 |
Why?
|